Valuation : Strides Pharma Science Limited

Market Cap 90.6B 950M 815M 765M 699M 1.32B 1.33B 9.06B 3.51B 45.71B 3.57B 3.49B 151B P/E 2027 *
14.4x
P/E 2028 * 10.3x
Enterprise Value 90.6B 950M 815M 765M 699M 1.32B 1.33B 9.06B 3.51B 45.71B 3.57B 3.49B 151B EV / Sales 2027 *
1.56x
EV / Sales 2028 * 1.31x
Free-Float
68.12%
Yield 2027 *
0.31%
Yield 2028 * 0.31%
1 day+0.01%
1 week+2.66%
Current month-4.10%
1 month-5.75%
3 months-15.93%
6 months+13.88%
Current year+9.18%
1 week 970
Extreme 970
1,056
1 month 931.3
Extreme 931.3
1,100
Current year 768.65
Extreme 768.65
1,231
1 year 768.65
Extreme 768.65
1,231
3 years 433.7
Extreme 433.7
1,675
5 years 263.35
Extreme 263.35
1,675
10 years 263.35
Extreme 263.35
1,675
Manager TitleAgeSince
Chief Executive Officer - 31/05/2024
Director of Finance/CFO 42 31/05/2024
Chief Tech/Sci/R&D Officer - 20/11/2024
Director TitleAgeSince
Chairman 65 -
Director/Board Member - 17/05/2017
Director/Board Member 82 17/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
+0.01%+2.66%+14.27%+124.33% 950M
+0.73%+0.70%+19.56%+71.29% 47.78B
-0.37%+1.04%+54.31%+121.86% 40.3B
+1.23%-0.14%-10.12%+15.55% 11.88B
+3.41%+7.67%+20.38%+87.48% 12.03B
+0.19%0.00%+30.98%+150.00% 9.24B
+0.45%+3.80%+25.19%+46.12% 7.83B
-1.41%-0.16%+52.26%-11.99% 7.34B
+0.89%+9.50%+26.11%+220.67% 7.21B
+0.95%-8.22%-39.88%+16.67% 5.28B
Average +0.62%+1.47%+19.31%+84.20% 14.98B
Weighted average by Cap. +0.55%+1.07%+27.41%+86.83%

Financials

2027 *2028 *
Net sales 58.23B 611M 524M 492M 449M 848M 852M 5.82B 2.26B 29.38B 2.29B 2.24B 97.3B 69.12B 725M 622M 584M 533M 1.01B 1.01B 6.91B 2.68B 34.87B 2.72B 2.66B 115B
Net income 6.28B 65.82M 56.49M 53.02M 48.43M 91.39M 91.83M 627M 243M 3.17B 247M 242M 10.49B 8.8B 92.24M 79.17M 74.31M 67.87M 128M 129M 879M 341M 4.44B 346M 339M 14.7B
Net Debt - -
Logo Strides Pharma Science Limited
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Employees
3,535
Date Price Change Volume
27/08/26 983.00 +0.01% 94,124
26/08/26 ₹982.90 -0.38% 97,630
25/08/26 ₹986.60 -0.70% 209,006
24/08/26 ₹993.60 +0.75% 220,560
21/08/26 ₹986.20 -0.68% 341,043
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
982.90INR
Average target price
1,338.67INR
Spread / Average Target
+36.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STAR Stock